In contrast, the immunity score exhibited a decreasing trend during the intermediate phase ( Figure 8 I), suggesting attenuation of immune-associated programs.
← all excerpts
Multi-Omics Analyses Identify <i>ANLN</i> as a Prognostic Biomarker for Recurrence and Metastasis in Non-Small Cell Lung Cancer.
1
—
—